Deal snapshot: Boehringer Ingelheim Signs Option to Acquire US Biotech Trutino Biosciences.

MANews-(C)2009-2022

Germany-based pharmaceutical company Boehringer Ingelheim has signed an option to acquire San Diego, US-based biotech Trutino Biosciences Inc, the company said.

Trutino Biosciences is a pre-clinical stage biotech company dedicated to the discovery and development of...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT